Top Markets
Coin of the day
Grace Therapeutics, Inc. Grace Therapeutics, Inc.

Grace Therapeutics, Inc.

GRCE
株式のランク #27036
Grace Therapeutics, Inc. specializes in the creation and commercialization of... Grace Therapeutics, Inc. specializes in the creation and commercialization of pharmaceutical products, primarily targeting uncommon and neglected diseases, with operations centered in Canada. The company's most advanced experimental treatment is GTX-104, an intravenous infusion designed to address subarachnoid hemorrhage. Its development pipeline further includes GTX-102, an oral mucosal betamethasone spray intended for the management of ataxia-telangiectasia, and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. Established in 2002, the enterprise previously operated under the name Acasti Pharma Inc., before officially adopting Grace Therapeutics, Inc. in October 2024. The company's main offices are located in Princeton, New Jersey.
株価
$2.18
最終同期: 2026-08-19
時価総額
$35.55M
変化(1日)
2.57%
変化(1年)
-33.19%
US
取引 Grace Therapeutics, Inc. (GRCE)

カテゴリー

Grace Therapeutics, Inc.(GRCE)の株価履歴
終値の最高値: $2.13 (2026-08-01)

終値の最安値: $3.24 (2024-10-01)
Grace Therapeutics, Inc. の株価履歴(2024 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -5.78%
2025 -13.39%
2024 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$758.23 6.53%
CH